Home › Forums › Main Forum › Media & News › Japan regulates pricing of Harvoni and Solvadi

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • 25 January 2016 at 5:05 pm #10397
    Avatar photoJoy
    • Guardian Angel
    • ★★★★★
    @joy

    http://pj.jiho.jp/servlet/pjh/regulatory/outline/1226583853271.html

    25 January 2016 at 5:43 pm #10402
    avatar876.jpegGaj
    • Guardian Angel
    • ★★★★★
    @gaj

    Interesting approach, slash max retail price and force wholesalers to renegotiate with the manufacturers?

    G3a since ’78 – Dx ’12 – F4 (2xHCC)
    24wk Tx – PEG/Riba/Dac 2013 relapsed
    24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
    16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
    SVR7 – 22/06/17 UND
    SRV12 – 27/07/17 UND
    SVR24 – 26/10/17 UND
    :cheer: :cheer: :cheer:

    26 January 2016 at 12:54 am #10411
    Avatar photoLondonGirl
    • Guardian Angel
    • ★★★★★
    @londongirl

    Wow – That’s pretty amazing – Good on Japan!
    The pressure is building.

    GT1a Dec14 F2/8.7 VL 900000-2.5M
    Jan16 Hepcivir-L MonkMed/Redemption
    Baseline: VL 913575 Alt 76 Platelets low
    Wk2 VL1157 Alt 23
    DET Wk 8 VL 32 Alt19 ‘In the slow lane’
    June16 Fibro 5.7 F0/1 LIF 1.5
    Wk 11 VL<12 Alt 13 Det/Unq
    Extending tx 12 wks Mylan Sofo/Dac MonkMed
    Wk 14 VL <12 Det/Unq
    Wk 16 VL UNDETECTED
    Wk 22 + 4 Wks Sunprevir FixHepC
    Wk 24 UNDETECTED Alt 13
    Wk 12 post tx SVR12 Wk 26 SVR24
    Thank-you Tim, Dr Debasis @ MonkMed & Dr Freeman @ Fix HepC

  • Author
    Posts
Viewing 3 posts - 1 through 3 (of 3 total)
  • You must be logged in to reply to this topic.